← All tickers

Is DFTX Worth Buying in 2026?

Definium Therapeutics, Inc. Common Shares

STOCK MEDICINAL CHEMICALS & BOTANICAL PRODUCTS Updated 2026-06-07

Here’s whether Definium Therapeutics, Inc. Common Shares (DFTX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+5.17% over 10 days); RSI 63 — healthy momentum range; 3-month momentum positive (+28.3%); rising volume confirms the move (1.27x 30d avg). Currently 10.3% off its 52-week high. Score: +5/7.

Ready to act on this? 📈 Trade on Webull

DFTX is trading below its 200-day MA (—) — a key warning sign the longer-term trend is under pressure. An RSI of 63.3 sits in the neutral zone — momentum is neither stretched nor exhausted. With ~5 months of trading history, the return since first available bar is +53.1%.

$10,000 invested 5 months ago → $15,312 today

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 50-day MA ($21.84)
✓Above 13-day MA ($22.98)
✓RSI(7) neutral zone (30–70) — currently 50.3
✓Positive return (+28.3%)
!Within 10% of period high (−10.3%)
Period Range $23.55
$17.13 $26.25
RSI (7) 50.3
0 · OversoldOverbought · 100

Key Metrics

Price$23.55
Period Return+28.3%
Period High$26.25
Period Low$17.13
Drawdown−10.3%
MA-13$22.98
MA-50$21.84
RSI (7)50.3
Avg Volume (30d)1.8M
vs. SPYbeat by 19.6%

Trade DFTX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers